Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted
Clear filters

12,372 trials

Phase 3 N=1,421 Diabetic Retinopathy Candesartan Trials

Type 1 Diabetes
Primary: Number of Participants With a 2-step or Greater Increase in Early Treatment Diabetic Retinopathy Study (ETDRS) Severity Scale. — 178; 217 Participants — p=0.0508
AstraZeneca Results Apr 2012 15.1% serious AE View details

Phase 3 N=60 PROMUS Element Japan Small Vessel Trial

Atherosclerosis · Coronary Artery Disease
Primary: Major Adverse Cardiac Events (MACE) (Percentage of Participants With an Event) — 0.0 percentage of participants — p=<0.0001
Boston Scientific Corporation Results Apr 2012 18.3% serious AE View details

Phase 3 N=1,197 Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study

Venous Thromboembolism
Primary: Percentage of Participants With Symptomatic Recurrent Venous Thromboembolism [VTE] (i.e. the Composite of Recurrent Deep Vein Thrombosis [DVT] or Fatal or Non-fatal…
Bayer Results Apr 2012 9.3% serious AE View details